CLINICAL_TRIALS
trial_result
· 2014-09-25
Clinical Trial Update: Melatonin for Migraine Prevention [Phase 2]
Summary
A Phase 2 clinical trial evaluating melatonin for migraine prevention has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nordlandssykehuset HF | Conditions: Migraine | Phase 2 | Status: COMPLETED